Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Concentra Group Holdings Parent, Inc.

Healthcare US CON

24.92USD
0.17(0.69%)

Last update at 2026-06-04T20:00:00Z

Day Range

24.6425.38
LowHigh

52 Week Range

18.4424.62
LowHigh

Fundamentals

  • Previous Close 24.75
  • Market Cap2943.16M
  • Volume747378
  • P/E Ratio17.60
  • Dividend Yield1.09%
  • EBITDA421.37M
  • Revenue TTM2163.42M
  • Revenue Per Share TTM16.86
  • Gross Profit TTM 613.09M
  • Diluted EPS TTM1.30

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 223.78M 231.39M 242.63M 224.90M 275.56M
Minority interest -6.43400M -5.35400M -4.79600M -5.51600M -7.16100M
Net income 172.80M 166.54M 179.95M 166.73M 208.88M
Selling general administrative 203.31M 156.32M 152.00M 0.15M 0.16M
Selling and marketing expenses - - 151.85M 149.83M 157.55M
Gross profit 613.09M 527.98M 512.43M 408.19M 427.98M
Reconciled depreciation 75.82M 67.18M 73.05M 73.67M 82.21M
Ebit 333.07M 301.09M 287.10M 256.54M 307.42M
Ebitda 408.88M 368.26M 360.15M 330.20M 389.63M
Depreciation and amortization 75.82M 67.18M 73.05M 73.67M 82.21M
Non operating income net other - - - - -
Operating income 2087.58M 304.76M 287.63M 258.22M 270.26M
Other operating expenses 75.82M 1595.43M 1550.45M 1466.14M 1461.78M
Interest expense 109.29M 69.69M 114.04M 31.64M 31.86M
Tax provision 50.98M 59.50M 40.26M 52.65M 59.53M
Interest income 109.29M 73.37M 45.00M 33.22M -
Net interest income -109.29000M -69.69400M -114.03900M -31.64100M -31.85600M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 50.98M 59.50M 57.89M 52.65M 59.53M
Total revenue 2163.40M 1900.19M 1838.08M 1724.36M 1732.04M
Total operating expenses -1474.50600M 223.21M 224.80M 149.98M 157.71M
Cost of revenue 1550.32M 1372.22M 1325.65M 1316.17M 1304.06M
Total other income expense net -1863.80500M -73.37000M -45.00200M -33.32100M 5.30M
Discontinued operations - - - - -
Net income from continuing ops 172.85M 171.90M 132.43M 172.24M 216.04M
Net income applicable to common shares 328.34M 333.09M 359.89M 333.45M -
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3038.16M 2521.16M 2487.77M 2297.24M -
Intangible assets 242.56M 204.72M 224.77M 247.57M -
Earning assets - - - - -
Other current assets 45.30M 36.23M 46.85M 40.71M -
Total liab 2617.73M 2222.44M 1310.33M 1301.12M -
Total stockholder equity 393.28M 275.67M 1155.60M 973.32M -
Deferred long term liab - - - - -
Other current liab 218.54M 200.35M 179.42M 178.88M -
Common stock 1.29M 1.28M 470.30M 464.73M -
Capital stock 1.29M 1.28M - - -
Retained earnings 146.45M 13.55M 685.29M 508.59M -
Other liab - - - - -
Good will 1479.19M 1234.71M 1229.74M 1225.87M -
Other assets 44.58M 11.00M -154.21100M 5.24M -
Cash 79.90M 183.25M 31.37M 37.66M -
Cash and equivalents - - - - -
Total current liabilities 337.25M 307.19M 274.63M 279.63M -
Current deferred revenue - - 0.40M 0.05M -
Net debt 2022.72M 1768.11M 873.63M 1001.99M -
Short term debt 95.32M 85.53M 74.40M 72.97M -
Short long term debt 10.74M 10.09M 0.00145M 1.67M -
Short long term debt total 2102.62M 1951.37M 905.00M 1039.65M -
Other stockholder equity 248.90M 260.84M - - -
Property plant equipment 708.96M 633.52M 576.22M 533.93M -
Total current assets 383.10M 437.21M 294.42M 284.63M -
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 257.90M 217.72M 216.19M 206.26M -
Long term debt 1563.66M 1468.92M 0.47M 633.91M -
Inventory - - - - -
Accounts payable 21.00M 19.75M 20.41M 27.67M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3.35200M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 200.23M 11.00M 8.41M 5.24M -
Deferred long term asset charges - - - - -
Non current assets total 2655.06M 2083.96M 2193.35M 2012.61M -
Capital lease obligations 528.22M 472.36M 0.43M 404.07M -
Long term debt total 1563.66M 1468.92M 473.29M 633.91M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -71.26500M -75.30800M -57.75000M -61.79800M
Change to liabilities - - - - -
Total cashflows from investing activities -414.85700M -71.26500M -75.30800M -57.75000M -61.79800M
Net borrowings 90.39M 999.95M -161.69400M -184.68200M -326.89400M
Total cash from financing activities 32.10M -51.53100M -165.29100M -209.85800M -342.58900M
Change to operating activities - - - - -
Net income 172.80M 171.90M 184.74M 172.24M 216.04M
Change in cash -103.35500M 151.88M -6.28300M 6.73M -113.74900M
Begin period cash flow 183.25M 31.37M 37.66M 30.93M 144.68M
End period cash flow 79.90M 183.25M 31.37M 37.66M 30.93M
Total cash from operating activities 279.40M 274.68M 234.32M 274.34M 290.64M
Issuance of capital stock 0.00000M 511.20M 0.00000M 0.00000M -
Depreciation 75.82M 67.18M 73.05M 73.67M 82.21M
Other cashflows from investing activities -414.85700M 0.03M 0.04M 0.04M 5.09M
Dividends paid 32.08M 1543.64M 6.13M 6.29M 6.71M
Change to inventory - - - - -
Change to account receivables -11.13600M -1.59800M -10.26200M -5.93100M 12.52M
Sale purchase of stock -22.42300M -15.40300M -5.32200M -29.05000M -23.40100M
Other cashflows from financing activities -3.78200M -3.63400M 4.51M 3.87M -15.69500M
Change to netincome - - - - -
Capital expenditures 82.33M 64.33M 69.34M 45.98M 46.79M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 7.96M 30.18M -18.70000M 33.92M -7.27800M
Stock based compensation 10.49M 2.33M 0.65M 2.14M 2.14M
Other non cash items 98.64M 5.50M 0.86M 1.01M -1.14100M
Free cash flow 197.06M 210.35M 164.98M 228.35M 243.85M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CON
Concentra Group Holdings Parent, Inc.		 0.17 0.69% 24.92 17.60 15.97 1.36 7.47 2.29 12.13
HCA
HCA Healthcare, Inc.		 -1.4 0.39% 361.83 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.22 2.10% 10.72 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

Concentra Group Holdings Parent, Inc.

5080 Spectrum Drive, Addison, TX, United States, 75001

Key Executives

Name Title Year Born
Mr. William Keith Newton CEO & Director 1963
Mr. Matthew T. DiCanio M.B.A. President & CFO 1983
Mr. John A. deLorimier Executive VP and Chief Information & Technology Officer 1960
Mr. Timothy F. Ryan Executive VP & Chief Legal Counsel 1961
Dr. John R. Anderson DO, FACOEM Executive VP & Chief Medical Officer 1950
Ms. Su Zan Nelson CPA Executive VP & Chief Accounting Officer 1964
Mr. Thomas A. Devasia Executive VP and Chief Marketing & Innovation Officer 1970
Ms. Danielle Kendall Executive VP & Chief People Officer 1969
Mr. Giovanni Gallara Executive VP & Chief Clinical Services Officer 1975
Mr. Michael A. Kosuth Executive VP & COO of East 1958

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.